SCHEMBL668585

SCHEMBL668585

Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](OP(=O)(O)OP(=O)(O)O)[C@H]1O

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RNASEL Q05823 4/20 0.77
P2RY1 P47900 4/20 0.77
P2RY2 P41231 4/20 0.77
SRC P12931 2/20 0.77
SMN1; SMN2 Q16637 2/20 0.77
DNPH1 O43598 1/20 0.77
PRKAB2 O43741 1/20 0.77
TRPM2 O94759 1/20 0.77
LDHA P00338 1/20 0.77
ADRB2 P07550 1/20 0.77
FBP1 P09467 1/20 0.77
ADORA1 P30542 1/20 0.77
PRKAG1 P54619 1/20 0.77
PRKAA2 P54646 1/20 0.77
PDE4D Q08499 1/20 0.77
KCNH2 Q12809 1/20 0.77
PRKAA1 Q13131 1/20 0.77
PDE3A Q14432 1/20 0.77
TAS1R3 Q7RTX0 1/20 0.77
TAS1R1 Q7RTX1 1/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29675135 0.96 RNASEL (0.82) RNASELP2RY1P2RY2SRCSMN1; SMN2
SCHEMBL7260957 0.96 RNASEL (0.82) RNASELP2RY1P2RY2SRCSMN1; SMN2
SCHEMBL27254833 0.95 RNASEL (0.84) RNASELP2RY1P2RY2SRCSMN1; SMN2
SCHEMBL11413776 0.95 RNASEL (0.84) RNASELP2RY1P2RY2SRCSMN1; SMN2
SCHEMBL11522022 0.95 RNASEL (0.84) RNASELP2RY1P2RY2SRCSMN1; SMN2
SCHEMBL27354655 0.95 RNASEL (0.84) RNASELP2RY1P2RY2SRCSMN1; SMN2
SCHEMBL905456 0.93 RNASEL (0.79) RNASELP2RY1P2RY2SRCSMN1; SMN2
SCHEMBL29440267 0.93 RNASEL (0.79) RNASELP2RY1P2RY2SRCSMN1; SMN2
SCHEMBL8167524 0.93 ADORA1 (0.74) RNASELP2RY1P2RY2SRCSMN1; SMN2
SCHEMBL29539212 0.93 ADORA1 (0.74) RNASELP2RY1P2RY2SRCSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023230560-A1 TREATMENT OF ORGANIC ACIDEMIAS OR PANTOTHENATE KINASE ASSOCIATED NEURODEGENERATION WITH MODULATORS OF PANTOTHENATE KINASES COA THERAPEUTICS, INC. (US) 2023-11-30 WO disclosed
US-10208270-B2 Acyltransferases and uses thereof in fatty acid production BASF PLANT SCIENCE COMPANY GMBH (DE) 2019-02-19 US disclosed
EP-2585603-B1 ACYLTRANSFERASES AND USES THEROF IN FATTY ACID PRODUCTION BASF PLANT SCIENCE CO GMBH (DE) 2017-12-20 EP disclosed
US-20160272951-A1 ACYLTRANSFERASES AND USES THEREOF IN FATTY ACID PRODUCTION BASF PLANT SCIENCE COMPANY GMBH (DE) 2016-09-22 US disclosed
US-9388437-B2 Acyltransferases and uses thereof in fatty acid production BASF PLANT SCIENCE COMPANY GMBH (DE) 2016-07-12 US disclosed
EP-2585603-A1 ACYLTRANSFERASES AND USES THEROF IN FATTY ACID PRODUCTION BASF Plant Science Company GmbH (DE) 2013-05-01 EP disclosed
US-20130097733-A1 Acyltransferases and Uses Thereof in Fatty Acid Production BASF PLANT SCIENCE COMPANY GMBH (DE) 2013-04-18 US disclosed
WO-2012024189-A2 COMPOSITIONS AND METHODS FOR DETERMINING PREDISPOSITION TO DEVELOPING METABOLIC SYNDROME THE J. DAVID GLADSTONE INSTITUTES (US) 2012-02-23 WO disclosed
WO-2011161093-A1 ACYLTRANSFERASES AND USES THEROF IN FATTY ACID PRODUCTION BASF PLANT SCIENCE COMPANY GMBH (DE) 2011-12-29 WO disclosed